Prospective study of clinical profile of acute ischemic stroke in a tertiary care hospital of North India

Shobhit Shakya, Arvind Vaish, Pratibha Singh


Background: Owing to the recent demographic shifts and negative lifestyle changes, stroke is one of the leading causes of mortality across every income group in most of the countries. It is of the utmost importance to devolve into the clinical profile, etiology and management of patients with acute ischaemic stroke.

Methods: It is a prospective case control study. Data was collected using a pre-tested pro forma meeting the objectives of the study. Patients who consented were divided into two groups and complete examination and investigations were carried out.

Results: There were 94 patients with AIS enrolled for the study. The mean age was 56.2 years, of which 68.08% were males and 31.92% were females. The mean time for these patients to reach the health facility was 12.6 hours and only 36.17% of patients reached in the window period of 4.5 hours and were eligible for thrombolysis. Hypertension, Diabetes and smoking were the most common risk factors in this order among others.

Conclusions: There is poor awareness regarding identification of stroke related symptoms and warning signs as majority of patients were unable to reach the hospital in the window period making them ineligible for thrombolysis. The leading etiology runs in the direction of modifiable risk factors which can be corrected at a primary prevention level.


Ischaemic Stroke, Thrombolysis, Risk factors

Full Text:



GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379:2429-37.

Smith WS, English JD, Johnson SD. Cerebrovascular disease in Harrison’s Principles of Internal Medicine, D. Braunwald, McGraw-Hill, New York, NY, USA, 18th ed. 2012: 3270.

Brott TG, Haley Jr EC, Levy DE, Barsan W, Broderick J, Sheppard GL, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992 May;23(5):632-40.

Feigin V, Lawes C, Bennet D, Barker_Cello S, Parag V. Worldwide stroke incidence and early case fatality in 56 population based studies: a systematic review. Lancet Neurol. 2009;8(4):355-69.

Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M. Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-7.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.

Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue type plasminnogen activator for treatment of acute stroke : The standard treatment with Alteplase to reverse stroke (STARS) study. JAMA. 2000;283:1145-50.

Maskey A, Parajuli M, Kohli SC. A study of risk factors of stroke in patients admitted in manipal teaching hospital, Pokhara. Kathmandu Univ Med J (KUMJ). 2011;9(36):244-7.

Awad SM, Al-Jumaily HF, Al-Dulaimi KM, Abdulghafoor RH. Assessment of major risk factors among stroke patients. Saudi Med J. 2010;31(9):1028-31.

Ukoha OB, Ajaegbu O, Eke CO. A review of stroke cases in a military hospital in Nigeria. AFRIMEDIC. J. 2012;3(2):30-3.

Shah B. Development of sentinel health monitoring centers for surveillance of risk factors for non-communicable disease in India. Report from the Division of Non-communicable Diseases, Indian Council of Medical Research, New Delhi, India. 2005.

The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-25.

Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Mukherjee CS, et al. A prospective community based study of stroke in Kolkata, India. Stroke. 2007;38:906-10.

Lemogoum D, Degaute JP, Bovet P. Stroke prevention, treatment, and rehabilitation in sub-saharan Africa. Ame J Preventive Med. 2005 Dec 1;29(5):95-101.

Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ. 1996 Jul 20;313(7050):147.

Bradley WG. Neurology in clinical practice. Philadelphia, PA: Butterworth-Heinemann Elsevier.7th ed. 2008.

Yamaguchi T, Mori E, Minematsu K. Alteplase at 0.6 mg/kg for Acute Ischemic Stroke within 3 Hours of Onset Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810-5.